{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:32:00Z","timestamp":1791401520956,"version":"4.3.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Migraine in Poland study is the first large scale nationwide cross-sectional online survey of symptoms, approaches to management, treatment patterns, quality of life, and sociodemographic characteristics of the Polish migraine patients\u2019 cohort, conducted from August 2021 to June 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional online survey was designed based on the American Migraine Prevalence and Prevention (AMPP) Study. Participants were recruited through broad advertisement through various channels. The survey included questions allowing for the diagnosis of migraine without aura (MwoA) based on the third edition of the International Classification of Headache Disorders (ICHD-3). Moreover, the questionnaire assessed sociodemographic and headache features, comorbidities, consultation rates with medical professionals, as well as the use of abortive or preventive treatment, including non-pharmacological methods, psychological symptoms and the burden of migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A structured online questionnaire was submitted by 3225 respondents aged 13 to 80 (mean age 38.9, 87.1% women). In this group 1679 (52.7%) of participants fulfilled ICHD-3 diagnostic criteria for MwoA, which was in most cases (88.3%) confirmed by a medical professional in the past. In this group the average number of monthly headache days was 4.7, while 47.8% of participants had at least 4 migraine days per month. Mean Migraine Disability Assessment score was 42.65 (median 32).<\/jats:p>\n                    <jats:p>\n                      Among MwoA respondents, 1571 (93.6%) had consulted their headache with a medical professional in the past \u2013 mostly neurologists (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091450 (83.4%) and primary care physicians (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091393 (82.9%). In the MwoA cohort, 1553 (92.5%) of participants declared the current use of some form of treatment, although only 193 (11.5%) respondents were currently on preventive medications. The most prevalent comorbidities included: chronic rhinitis (37.1%), allergies (35.9%) and low blood pressure (26.9%). Anxiety (20.4%) and depression (21.3%) were highly prevalent among participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>People with migraine in Poland face similar difficulties as their peers in other countries. Despite relatively high access to neurologist consultations and good diagnosis accuracy, migraine still poses diagnostic and therapeutic difficulties. In this context, migraine undertreatment in Polish population must be underlined, especially in context of high disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-023-01575-4","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T08:03:04Z","timestamp":1681200184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Marta","family":"Waliszewska-Pros\u00f3\u0142","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Straburzy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa K.","family":"Czapi\u0144ska-Ciepiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Nowaczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gryglas-Dworak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Budrewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"19","key":"1575_CR1","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"AM Migraine","year":"2020","unstructured":"Migraine AM (2020) New E Journal Med 383(19):1866\u20131876","journal-title":"New E Journal Med"},{"key":"1575_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"372","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel YW, Cowan RP (2017) Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 372:307\u2013315","journal-title":"J Neurol Sci"},{"key":"1575_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E (2018) The prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache 58:496\u2013505","journal-title":"Headache"},{"key":"1575_CR4","unstructured":"Spo\u0142eczne znaczenie migreny z perspektywy zdrowia publicznego i ochrony zdrowia. Narodowy Instytut Zdrowia Publicznego \u2014 Pa\u0144stwowy Zak\u0142ad Higieny, Warszawa 2019. https:\/\/www.pzh.gov.pl\/wp-content\/uploads\/2019\/06\/RAPORT-MIGRENA-ca%C5%82y.pdf (March 1, 2021)."},{"issue":"10283","key":"1575_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485\u20131495. https:\/\/doi.org\/10.1016\/S0140-6736(20)32160-7","journal-title":"Lancet"},{"issue":"1","key":"1575_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20(1):41. https:\/\/doi.org\/10.1186\/s10194-019-0993-0. (Published 2019 Apr 25)","journal-title":"J Headache Pain"},{"key":"1575_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: Will health politicians now take notice? J Headache Pain 19:17","journal-title":"J Headache Pain"},{"issue":"8","key":"1575_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/13696998.2020.1754840","volume":"23","author":"R Mahon","year":"2020","unstructured":"Mahon R, Huels J, Hacking V et al (2020) Economic evaluations in migraine: systematic literature review and a novel approach. J Med Econ 23(8):864\u2013876. https:\/\/doi.org\/10.1080\/13696998.2020.1754840","journal-title":"J Med Econ"},{"issue":"9","key":"1575_CR9","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/head.13407","volume":"58","author":"RB Lipton","year":"2018","unstructured":"Lipton RB, Munjal S, Alam A et al (2018) Migraine in America Symptoms and Treatment (MAST) Study: baseline study methods, treatment patterns, and gender differences. Headache 58(9):1408\u20131426. https:\/\/doi.org\/10.1111\/head.13407","journal-title":"Headache"},{"issue":"1","key":"1575_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1129-2377-15-31","volume":"15","author":"TJ Steiner","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z et al (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15(1):31. https:\/\/doi.org\/10.1186\/1129-2377-15-31. (Published 2014 May 21)","journal-title":"J Headache Pain"},{"issue":"1","key":"1575_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"1575_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1526-4610.2001.01156.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Sawyer J, Edmeads JG (2001) Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) questionnaire. Headache 41:854\u2013861","journal-title":"Headache"},{"key":"1575_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jad.2020.09.131","volume":"279","author":"L Costantini","year":"2021","unstructured":"Costantini L, Pasquarella C, Odone A et al (2021) Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord 279:473\u2013483. https:\/\/doi.org\/10.1016\/j.jad.2020.09.131","journal-title":"J Affect Disord"},{"key":"1575_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14680770120042864","volume":"1","author":"L van Zoonen","year":"2010","unstructured":"van Zoonen L (2010) Feminist internet studies. Fem Media Stud 1:67\u201372","journal-title":"Fem Media Stud"},{"issue":"22","key":"1575_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12883-022-02968-9","volume":"21","author":"EV Dermitzakis","year":"2022","unstructured":"Dermitzakis EV, Kouroudi A, Argyriou AA, Spingos KC, Bilias K, Vikelis M (2022) Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine. BMC Neurol 21(22):440","journal-title":"BMC Neurol"},{"issue":"3","key":"1575_CR16","first-page":"178","volume":"27","author":"MT Vicente-Herrero","year":"2020","unstructured":"Vicente-Herrero MT, de la Ram\u00edrezI\u00f1iguez Torre MV, de la Ruiz Torre E, BarberoReinoso L (2020) Symptomatic treatment for migraine. Drugs used and related variables. Results of the European survey on work and migraine. Rev Soc Esp Dolor 27(3):178\u201391","journal-title":"Rev Soc Esp Dolor"},{"issue":"7","key":"1575_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41(7):638\u2013645","journal-title":"Headache"},{"issue":"1","key":"1575_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P (2018) My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain 19(1):115","journal-title":"J Headache Pain"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-016-0599-8","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Stovner LJ, Tassorelli C, Katsarava Z, La\u00ednez JM, Lant\u00e9ri-Minet M, Rastenyte D, Ruiz de la Torre E, Andr\u00e9e C, Steiner TJ (2016) Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain 17:9","journal-title":"J Headache Pain"},{"issue":"2","key":"1575_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, Buse DC, Shapiro RE, Ashina S, Cambron-Mellott MJ, Rowland JC, Pearlman EM (2022) Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study. Headache 62(2):122\u2013140","journal-title":"Headache"},{"issue":"2","key":"1575_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0333102418786266","volume":"39","author":"AI Scher","year":"2019","unstructured":"Scher AI, Wang S-J, Katsarava Z et al (2019) Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Cephalalgia 39(2):296\u2013305","journal-title":"Cephalalgia"},{"key":"1575_CR22","doi-asserted-by":"publisher","first-page":"175628642210959","DOI":"10.1177\/17562864221095902","volume":"15","author":"C Gottschalk","year":"2022","unstructured":"Gottschalk C, Buse DC, Marmura MJ et al (2022) The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review. Ther Adv Neurol Disord 15:17562864221095902","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1575_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s10194-023-01541-0","volume":"24","author":"A Onofri","year":"2023","unstructured":"Onofri A, Pensato U, Rosignoli C et al (2023) Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain 24(1):8","journal-title":"J Headache Pain"},{"issue":"11","key":"1575_CR24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","volume":"37","author":"K Hirata","year":"2021","unstructured":"Hirata K, Ueda K, Komori M et al (2021) Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin 37(11):1945\u20131955","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1575_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-2982.2006.01275.x","volume":"27","author":"S Silberstein","year":"2007","unstructured":"Silberstein S, Loder E, Diamond S et al (2007) Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia 27(3):220\u2013229","journal-title":"Cephalalgia"},{"issue":"1","key":"1575_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-019-1027-7","volume":"20","author":"C Piccinni","year":"2019","unstructured":"Piccinni C, Cevoli S, Ronconi G et al (2019) A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years. J Headache Pain 20(1):74","journal-title":"J Headache Pain"},{"issue":"1","key":"1575_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s10194-021-01252-4","volume":"22","author":"S Sacco","year":"2021","unstructured":"Sacco S, Lampl C, van den Maassen Brink A et al (2021) Burden and attitude to resistant and refractory migraine: a survey from the European headache federation with the endorsement of the European migraine & headache alliance. J Headache Pain. 22(1):39","journal-title":"J Headache Pain."},{"key":"1575_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C et al (2018) Poor medical care for people with migraine in Europe \u2013 evidence from the Eurolight study. J Headache Pain 19:10","journal-title":"J Headache Pain"},{"issue":"6","key":"1575_CR29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/archinte.1992.00400180125021","volume":"152","author":"RB Lipton","year":"1992","unstructured":"Lipton RB, Stewart WF, Celentano DD, Reed ML (1992) Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med 152(6):1273\u20131278","journal-title":"Arch Intern Med"},{"issue":"3","key":"1575_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ene.14098","volume":"27","author":"M Viana","year":"2020","unstructured":"Viana M, Khaliq F, Zecca C et al (2020) Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 27(3):536\u2013541","journal-title":"Eur J Neurol"},{"issue":"3","key":"1575_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/03331024211040753","volume":"42","author":"M Straburzy\u0144ski","year":"2022","unstructured":"Straburzy\u0144ski M, Nowaczewska M, Budrewicz S, Waliszewska-Pros\u00f3\u0142 M (2022) COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia 42(3):218\u2013228","journal-title":"Cephalalgia"},{"issue":"2","key":"1575_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0038-1646946","volume":"38","author":"D Saylor","year":"2018","unstructured":"Saylor D, Steiner TJ (2018) The Global Burden of Headache. Semin Neurol 38(2):182\u2013190","journal-title":"Semin Neurol"},{"issue":"8","key":"1575_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514","journal-title":"Nat Rev Neurol"},{"key":"1575_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s10194-022-01513-w","volume":"23","author":"I Peles","year":"2022","unstructured":"Peles I, Asla M, Abayev M et al (2022) Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting. J Headache Pain 23:160","journal-title":"J Headache Pain"},{"issue":"3","key":"1575_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"AM Blumenfeld","year":"2011","unstructured":"Blumenfeld AM, Varon SF, Wilcox TK et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31(3):301\u2013315","journal-title":"Cephalalgia"},{"issue":"1","key":"1575_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10194-018-0907-6","volume":"19","author":"P Vo","year":"2018","unstructured":"Vo P, Fang J, Bilitou A et al (2018) Patients\u2019 perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain 19(1):82","journal-title":"J Headache Pain"},{"issue":"4","key":"1575_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/head.14289","volume":"62","author":"L Harris","year":"2022","unstructured":"Harris L, L\u2019Italien G, Kumar A, Seelam P, LaVallee C, Coric V, Lipton RB (2022) Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States. Headache 62(4):473\u2013481","journal-title":"Headache"},{"key":"1575_CR38","unstructured":"https:\/\/stat.gov.pl\/spisy-powszechne\/nsp-2021\/nsp-2021-wyniki-ostateczne\/"},{"issue":"10","key":"1575_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0333102411410610","volume":"31","author":"KA Payne","year":"2011","unstructured":"Payne KA, Varon SF, Kawata AK et al (2011) The international burden of migraine study (IBMS):study design, methodology and baseline cohort characteristics. Cephalalgia 31(10):1116\u20131130","journal-title":"Cephalalgia"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01575-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T08:03:11Z","timestamp":1681200191000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01575-4"}},"subtitle":["Results from \u2018Migraine in Poland\u2019\u2014a nationwide cross-sectional survey"],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01575-4","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered as \"Migraine in Poland \u2013 a Web-based Cross-sectional Survey\" in the ClinicalTrials.gov database under the number: NCT05087420. The project was approved by the Commission of Bioethics at the Wroclaw Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}